DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Biomarkers for advancing diagnosis and prognosis in stroke
The complexity and incomplete understanding of the pathophysiology of stroke poses substantial challenges to personalised medicine and the development of novel therapies, as reflected in the neutral results of many randomised trials. Current clinical algorithms lack the precision to diagnose stroke before hospital admission, predict disease progression and recovery, or assess recurrence risk. Biomarkers are urgently needed, yet the absence of a robust evidence base hinders their clinical translation. To lay the groundwork for addressing this knowledge gap, an international multidisciplinary panel of stroke experts conducted a literature review that informed a Delphi consensus process. The stroke experts panel proposes 17 research priorities and five minimum reporting datasets for stroke biomarker studies, each corresponding to a key domain of stroke care: prehospital diagnosis, ischaemic stroke progression, atrial cardiopathy, plaque vulnerability, and intracerebral haemorrhage. This framework will promote consistency and collaboration towards the discovery, validation, and clinical translation of biomarkers to improve stroke care., AB received financial support from the Spanish Ministry of Science and Innovation (RD24/0009/0015 and PI21/00939) and from the JMC Legacy Research Fund of Germans Trias I Pujol University Hospital (LC2307). AK received funding from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy – ID 390857198). CJ received support from the Swedish Heart and Lung Foundation (20220184), the Swedish Research Council (2021-01114), and the Swedish state under the agreement between the Swedish government and the county councils, the ALF agreement (ALFGBG-965328). PC-R received financial support from the Spanish Ministry of Science and Innovation (RD24/0009/0010). JJML received research grants from the British Heart Foundation, the UK Dementia Research Institute, the UKE Chief Scientist Office, and the British Irish Association of Stroke Physicians. JK-T is recipient of a Wellcome Trust Early Career Award (304532/Z/23/Z). KMD received research support from Research Ireland (grant number 13/RC/2073_P2). AGL received funding (paid to institution) from The Swedish Government (under the “Avtal om Läkarutbildning och Medicinsk Forskning, ALF”), The Swedish Heart and Lung Foundation, The Swedish Brain Foundation, The FGS Fang foundation, The Swedish Stroke Association, Region Skåne, Lund University, the National Institutes of Health (1R01-NS114045), and the Fremasons Lodge of Instruction Eos in Lund (all paid to institution). BC received support from EBRAINS, the European digital research infrastructure for neuroscience (Horizon Europe: 101147319); and travel grants from the European Academy of Neurology, the European Stroke Organization, the German Stroke Organization, and the German Neurological Organization. CHN received a research grant from the Berlin Institute of Health. FHBMS received a NWO ZonMw Veni grant from the Dutch Scientific Council (09150162310154). GMG received research support from the German Research Foundation (grant number: DFG, ME 3696/3-1), the European Commission, the Ministry of Science and Culture Lower Saxony, and the German Federal Ministry of Education and Research. H-HT received a stipend for a presentation at the International Society on Thrombosis and Haemostasis; and travel support from the Taiwan National Science and Technology Council. JA received support from The Bissen Brainwalk Foundation, Uppsala County Association Against Heart and Lung Diseases, Hjärt-Lungfonden (The Swedish Heart Lung Foundation), Uppsala University Hospital, and Uppsala University, Sweden. JMC received financial support from the Dutch Heart Foundation. JJM received research grants from the Irish Institute of Clinical Neuroscience and the University College Dublin. JM received financial support from the Spanish Ministry of Science, Innovation and Universities (AEI 2021-TED2021-131742B-I00 G-MC), the Instituto de Salud Carlos III (PI21/01158, DTS22/00078), the General Secretariat for research, development and innovation in biomedicine and health sciences in Andalusia (PIP-0009-2021), and ERA-NET NEURON (CV_056 CRESCENDO). JO received research fellowship grants from the Radiological Society of North America (RSNA) and the Canadian Association of Radiologists. MDH received grants from the Canadian Institutes of Health Research and the Heart & Stroke Foundation of Canada. MK received grants from the Swiss National Science Foundation (142422), the Swiss Heart Foundation, and Horizon Europe (ERANET-NEURON). NSa received grants from The Stroke Association (SA SCLM 23\100002) and NHS Research. MHS received grants from the National Institute of Neurological Disorders and Stroke (U01NS102289) and the National Institute of Aging (UF1NS120871). RA-SS received research grants from the British Heart Foundation, the Chief Scientist Office Health Improvement, Protection and Services Research committee, and from the European Stroke Masters of the European Stroke Organization. ST received research grants from the Corona foundation, the Leducq foundation (21CVD04), the German Federal Ministry of Education and Research (European Joint Program for Rare Diseases, EJPRD23-010), and the LMU (LMUexcellent: NFF-1507; Medical & Clinician Scientist Program (MCSP): ACS-16)., Peer reviewed
Proyecto:
EC / HE 101147319
,
AEI TED2021-131742B-I00
DOI: http://hdl.handle.net/10261/437159, https://api.elsevier.com/content/abstract/scopus_id/105034086888
HANDLE: http://hdl.handle.net/10261/437159, https://api.elsevier.com/content/abstract/scopus_id/105034086888